| Trial ID: | L2449 |
| Source ID: | NCT03958591
|
| Associated Drug: |
Csii And Thereafter Combination Therapy, Followed Up With Wearable Devices
|
| Title: |
Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification
|
| Acronym: |
ESTIMATOR
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes type2
|
| Interventions: |
DRUG: CSII and thereafter combination therapy, followed up with wearable devices|DRUG: CSII and thereafter combination therapy, followed up in traditional ways|DRUG: Traditionally upgrading therapy, followed up in traditional ways
|
| Outcome Measures: |
Primary: the proportions of treatment simplification, the proportions of patients who can maintain glycemic targets (HbA1c\<7%) with only combination of oral hypoglycemic agents, 24 weeks after the insulin treatment |
|
| Sponsor/Collaborators: |
Sponsor: Yanbing Li
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
274
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2019-05-01
|
| Completion Date: |
2022-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2022-04-08
|
| Locations: |
Department of endocrinology, FAH-SYSU, Guangzhou, Guangdong, 510080, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03958591
|
